Biological wastewater treatment: how it works and when to use it

What is biological wastewater treatment?

Wastewater treatment is the process of removing contaminants—suspended solids, organic matter, nutrients, and pathogens—from used water so it can be safely discharged or reused. Within that broader field, biological wastewater treatment refers specifically to using living microorganisms to break down dissolved organic pollutants and remove nutrients from effluent. Bacteria, fungi, and protozoa metabolize the organic load, converting harmful compounds into carbon dioxide, water, and stable biomass.

Why does this matter at the scale of 2026 American infrastructure? According to the American Society of Civil Engineers' 2025 infrastructure report card, the US operates approximately 17,500 publicly owned treatment works (POTWs) serving roughly 238 million people. The EPA's most recent Clean Watersheds Needs Survey estimated a $630 billion infrastructure gap over the next two decades. Biological processes sit at the core of virtually every one of those facilities—they are neither a niche technology nor a new invention, but they are evolving rapidly in response to tightening nutrient limits, energy costs, and the emerging PFAS crisis.

For a broader technical foundation, see this wastewater treatment overview from Wikipedia, which maps the full spectrum of physical, chemical, and biological unit processes.

How does biological treatment differ from physical and chemical methods?

Physical processes—screening, sedimentation, filtration—remove solids without transforming them. Chemical methods such as coagulation, precipitation, and disinfection alter contaminant structure through reagent addition. Biological treatment is distinct because microorganisms actually consume and metabolize organic matter, making it the most cost-effective approach for high-strength, high-volume organic waste streams. That said, it rarely operates in isolation. Most full-scale systems combine all three categories across primary, secondary, and tertiary treatment stages.

Where is biological treatment used?

Applications span two broad domains. Municipal wastewater—domestic sewage collected through city sewer systems—relies almost universally on biological secondary treatment to meet Clean Water Act discharge standards. Industrial wastewater from sectors like food and beverage processing, pharmaceutical manufacturing, pulp and paper, and petroleum refining often requires biological effluent treatment either on-site before discharge or as pretreatment before connecting to a municipal sewer. The selection logic between these scenarios is addressed in detail in Section 4.

How the biological treatment process works: step by step

Biological treatment never operates as a standalone unit—it is embedded within a multi-stage sequence. Understanding each stage is essential before selecting a technology or evaluating compliance requirements.

1. Preliminary treatment: Screening and grit removal protect downstream equipment by catching rags, plastics, and heavy particles. No biological activity occurs here.
2. Primary treatment (settling): Gravity sedimentation removes 50–70% of suspended solids and 25–40% of BOD₅ (five-day biochemical oxygen demand). The settled material becomes primary sludge.
3. Secondary biological treatment: Microorganisms in aerated reactors consume dissolved organics. This stage typically achieves 85–95% BOD removal and 85–92% TSS removal, meeting secondary treatment standards under 40 CFR Part 133.
4. Secondary clarification: Biomass (activated sludge) is separated from treated effluent by gravity settling. A portion is returned to the aeration basin (return activated sludge, or RAS); excess is wasted (WAS).
5. Tertiary treatment: Advanced processes—biological nutrient removal (BNR), membrane filtration, UV or chlorine disinfection—polish effluent to meet nutrient limits, reuse standards, or permit-specific thresholds.
6. Biosolids management: Settled biomass undergoes anaerobic digestion, dewatering, and either land application or disposal. Biosolids management is increasingly complex under 2026 PFAS guidance (see Section 6).

Think of this sequence like a layered filtration system in a water purifier—each stage handles what the previous one cannot. No single process does everything, and skipping a stage invariably creates compliance or operational problems downstream.

What happens inside the aeration basin?

The aeration basin is the biological engine of secondary treatment. Mixed liquor—a suspension of wastewater and active microbial communities—is continuously aerated to maintain dissolved oxygen (DO) above 1.5–2.0 mg/L. Heterotrophic bacteria oxidize carbonaceous BOD; nitrifying bacteria (Nitrosomonas and Nitrobacter) convert ammonia to nitrate in a two-step process called nitrification. In systems designed for full nitrogen removal, anoxic zones allow denitrifying bacteria to convert nitrate to nitrogen gas—this is the basis of biological nitrogen removal (BNR).

How is phosphorus removed biologically?

Enhanced biological phosphorus removal (EBPR) exploits a group of organisms called polyphosphate-accumulating organisms (PAOs). When PAOs cycle through anaerobic and aerobic zones, they accumulate intracellular polyphosphate far beyond normal metabolic needs. By wasting the phosphorus-rich biomass (WAS), operators can achieve effluent total phosphorus below 0.5 mg/L without chemical precipitation—a significant operating cost advantage over alum or ferric chloride addition at large-scale facilities.

Key biological treatment technologies compared

The activated sludge process dominates US municipal practice, but it is far from the only option. Actual selection depends on flow volume, land availability, permit limits, and the nature of the wastewater.

Technology	Typical application	BOD removal	Footprint	Energy use (kWh/Mgal)	Capital cost range (USD/MGD)
Conventional activated sludge (CAS)	Municipal, >1 MGD	90–95%	Large	1,500–2,500	$3M–$8M
Membrane bioreactor (MBR)	Water reuse, space-constrained sites	>98%	Compact	3,000–5,000	$8M–$18M
Sequencing batch reactor (SBR)	Small municipalities, variable flows	88–95%	Moderate	1,800–3,000	$2.5M–$7M
Moving bed biofilm reactor (MBBR)	Industrial pretreatment, retrofits	85–92%	Compact	1,200–2,200	$1.5M–$5M
Trickling filter	Rural, low-energy settings	80–90%	Large	500–1,000	$1M–$3M
Anaerobic digestion (high-strength)	Food processing, brewery, dairy	60–80% (pre-aerobic)	Moderate	Net energy positive	$2M–$10M

Sources: WEF Manual of Engineering Practice, EPA Wastewater Technology Fact Sheets, 2026 Water Environment Federation survey data. Capital costs are indicative ranges; site-specific engineering is required.

Suspended growth vs. attached growth: which is better?

Suspended growth systems like activated sludge keep microorganisms in continuous suspension within the liquid phase. Attached growth (biofilm) systems like MBBRs and trickling filters immobilize microorganisms on media surfaces. In practice, suspended growth systems offer tighter process control and higher BOD removal efficiency, while attached growth systems excel in retrofit scenarios where adding tankage is not feasible. Many modern facilities use integrated fixed-film activated sludge (IFAS), combining both approaches to increase capacity without expanding footprint—a strategy that has seen significant adoption across the Midwest and Southeast over the past three years.

When does anaerobic treatment make sense?

Anaerobic biological treatment—where microorganisms degrade organics in the absence of oxygen—is the preferred first stage for high-strength industrial wastewaters with BOD above 2,000 mg/L. Upflow anaerobic sludge blanket (UASB) reactors and anaerobic lagoons are common in food and beverage and agricultural processing. The process generates biogas (60–70% methane), which can offset facility energy costs substantially. However, anaerobic effluent rarely meets discharge limits alone and must be followed by aerobic polishing.

When to use biological wastewater treatment: a decision guide

Not every wastewater stream is a candidate for biological treatment—and choosing incorrectly wastes capital, creates compliance failures, and can destroy the microbial communities that make the process work. The decision hinges on three variables: wastewater composition, discharge destination, and site constraints.

Municipal vs. industrial wastewater: different problems, different solutions

Municipal wastewater is relatively predictable in composition. BOD₅ typically ranges from 150–300 mg/L, total nitrogen from 35–50 mg/L, and total phosphorus from 4–12 mg/L. Conventional activated sludge with BNR handles this range reliably, and the regulatory framework—secondary treatment standards under 40 CFR 133 plus permit-specific nutrient limits—is well-established.

Industrial wastewater is far more variable. A dairy plant effluent might carry 3,000–8,000 mg/L BOD; a pharmaceutical facility might discharge trace active pharmaceutical ingredients (APIs) that inhibit nitrifiers; a metal finishing shop may have heavy metals that are toxic to biological cultures entirely. The decision framework below applies to both contexts.

"Biological treatment is not a universal solution—it is an elegant solution for the right problem. When the organic load is high and the inhibitory compounds are low, no technology delivers lower cost per pound of BOD removed." — Water Environment Federation, Design of Municipal Wastewater Treatment Plants, 6th Ed.

Decision criteria: is biological treatment right for your situation?

Use biological treatment as the primary strategy when: (1) BOD₅ exceeds 100 mg/L and the waste is predominantly biodegradable organic material; (2) ammonia or total nitrogen limits apply in the NPDES permit; (3) phosphorus limits are below 1 mg/L and chemical precipitation costs are prohibitive; or (4) water reclamation and reuse are end goals. Conversely, biological treatment alone is insufficient when the waste contains significant concentrations of heavy metals, non-biodegradable synthetic organics, or PFAS compounds. In those cases, biological treatment must be preceded or followed by physical-chemical unit processes.

For industrial facilities discharging to a municipal sewer under an industrial pretreatment program, check local pretreatment limits before designing a biological system—some POTWs require BOD reduction to below 300 mg/L at the point of discharge, while others allow higher loads with surcharge fees. The EPA's wastewater treatment factsheets provide technology-specific guidance organized by sector.

Cost, energy use, and carbon footprint: 2026 data

One of the most persistent gaps in publicly available guidance is hard cost data. Based on recent engineering surveys and Water Research Foundation benchmarking reports, the following figures reflect 2026 US conditions for facilities in the 1–10 MGD range.

Operating cost breakdown for a 5 MGD activated sludge facility

Cost category	Annual cost (USD)	% of total O&M	Cost driver notes
Aeration energy	$420,000–$650,000	45–55%	Largest single cost; DO control critical
Biosolids disposal	$180,000–$350,000	20–28%	PFAS restrictions increasing landfill costs
Chemicals (coagulants, disinfection)	$80,000–$140,000	8–12%	Ferric chloride for supplemental P removal
Labor	$200,000–$300,000	18–22%	Operator certification requirements vary by state
Maintenance and parts	$50,000–$90,000	5–8%	Blower/diffuser replacement dominant

Energy is the dominant cost lever. Aeration alone consumes 45–55% of total plant energy—which means fine bubble diffusion upgrades, real-time DO control via automated SCADA, and blower efficiency improvements consistently deliver the fastest ROI. A 2026 Water Research Foundation survey of 38 US facilities found that plants implementing automated DO control reduced aeration energy by an average of 22%, translating to $90,000–$180,000 per year in savings at mid-size facilities. From a carbon perspective, a conventional 5 MGD activated sludge plant emits approximately 1,800–2,400 metric tons CO₂-equivalent annually, with aeration contributing the majority of Scope 2 emissions.

Does upgrading to nutrient removal significantly increase costs?

Adding BNR to an existing conventional activated sludge system typically increases capital costs by 15–30% and operating costs by 8–18%, depending on whether anaerobic/anoxic zone reconfiguration is feasible within existing tankage. When EBPR is functioning well, it can actually reduce chemical costs enough to offset the added complexity. Of course, EBPR performance is sensitive to influent BOD:P ratios and dissolved oxygen intrusion into anaerobic zones—real-world results vary, and some facilities find that supplemental chemical addition remains necessary during winter low-temperature periods.

Regulatory compliance: NPDES, Clean Water Act, and PFAS in 2026

Every wastewater discharge in the United States is governed by the National Pollutant Discharge Elimination System (NPDES), established under the Clean Water Act compliance framework. Understanding current permit structure—and where it is heading—is non-negotiable for any facility operator or engineer.

How do NPDES permit limits vary by state?

Federal secondary treatment standards set a floor: effluent BOD₅ and TSS must not exceed 30 mg/L (30-day average) and 45 mg/L (7-day average). Above that floor, permit limits are set by state agencies on a permit-by-permit basis, guided by water quality standards for the receiving water body. The practical variation is substantial. Chesapeake Bay watershed permits in Virginia and Maryland impose total nitrogen limits as low as 3–4 mg/L and total phosphorus limits of 0.1 mg/L—requiring advanced tertiary treatment. By contrast, many inland states in the Mountain West still issue secondary-only permits without numeric nutrient limits. Facilities in the Great Lakes basin face intermediate requirements under the Great Lakes Initiative (GLI), which establishes water quality criteria for bioaccumulative toxics and nutrients.

For up-to-date permit guidance specific to your state, the WHO's resource on wastewater use and sanitation provides international context that can inform water reuse standards at the state level.

What does the 2026 PFAS regulatory shift mean for treatment operators?

This is the most significant regulatory development currently reshaping wastewater management. In July 2026, EPA published updated risk guidance for PFOA and PFOS in biosolids, and the agency has formally proposed incorporating PFAS effluent monitoring requirements into NPDES permits for industrial categories known to be PFAS sources—including electroplating, textile finishing, and chrome plating. Why should biological treatment operators care? Because conventional biological processes do not degrade PFAS. Per- and polyfluoroalkyl substances pass through activated sludge systems largely intact, concentrate in biosolids, and create significant disposal liability. Facilities receiving high-PFAS industrial loads are now evaluating granular activated carbon (GAC) polishing, ion exchange, or advanced oxidation processes (AOP) downstream of secondary biological treatment. The Water Research Foundation's wastewater research programs are actively funding pilot studies on biological-GAC hybrid systems for simultaneous BOD, nutrient, and PFAS management.

Emerging contaminants and the limits of biological treatment

Biological treatment is extraordinarily effective for what it was designed to do—removing biodegradable organics and, with BNR, nutrients. But the contaminant landscape has shifted materially since the foundational activated sludge patents of the early 20th century. Today's operators face pollutants that microbiology simply was not evolved to handle.

Which contaminants escape biological treatment?

PFAS, as discussed above, are the most acute regulatory concern. But the list is longer. Microplastics pass through most biological secondary systems and are only partially removed in tertiary membrane filtration. Endocrine-disrupting compounds (EDCs)—including pharmaceuticals like synthetic estrogens and anti-inflammatory drugs—are partially removed by biological processes, with studies showing 50–95% removal for some compounds but near-zero removal for others like carbamazepine and certain sulfonamide antibiotics. Heavy metals accumulate in biosolids rather than being destroyed, creating land-application restrictions. For facilities facing these challenges, biological treatment remains a necessary foundation, but the water reclamation system must be designed with post-biological polishing as a standard component, not an afterthought.

What is the future of biological treatment technology?

Mainstream research points toward three converging directions. First, anaerobic ammonium oxidation (anammox)—a low-energy biological nitrogen removal pathway that bypasses conventional nitrification-denitrification—is transitioning from pilot scale to full-scale implementation at several major US POTWs, with energy savings of 40–60% over conventional BNR. Second, resource recovery framing is replacing "waste" framing: modern water reclamation plants are being designed to harvest nitrogen and phosphorus as struvite fertilizer, generate biogas for combined heat and power (CHP), and produce Class A biosolids for beneficial reuse—when PFAS content permits. Third, real-time sensor integration and machine learning-based process optimization are enabling tighter control of biological systems, reducing both energy use and permit exceedances. According to recent industry analysis, the global biological wastewater treatment market is on a sustained growth trajectory through 2030, driven largely by US and European nutrient regulation tightening and water recycling mandates in arid states.

Conclusion: matching the right biological process to the right problem

Biological wastewater treatment is not a monolithic technology—it is a toolkit of microbiology-based unit processes, each optimized for specific wastewater characteristics, permit conditions, and site constraints. The activated sludge process remains the workhorse of US municipal water pollution control, reliably achieving secondary treatment standards at acceptable cost. But 2026's regulatory environment—tighter nutrient limits, emerging PFAS obligations, and water reuse mandates—demands more. Engineers and operators who understand the interplay between process selection, energy management, biosolids compliance, and emerging contaminant risk will deliver both regulatory certainty and long-term cost performance. For a comprehensive view of treatment technology research, the wastewater research programs at the Water Research Foundation remain the leading US source for peer-reviewed engineering guidance.